<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02831647</url>
  </required_header>
  <id_info>
    <org_study_id>AY:AC1</org_study_id>
    <nct_id>NCT02831647</nct_id>
  </id_info>
  <brief_title>Acceptability and Tolerance Study of New Oral Nutritional Supplement PRAGUE</brief_title>
  <official_title>Tolerance and Acceptability of AYMES PRAGUE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aymes International Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eat Well Now</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aymes International Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tolerance and Acceptability of new oral nutritional supplement - AYMES PRAGUE
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate tolerance and acceptability of AYMES PRAGUE in patients requiring supplementary
      oral nutritional support compared with currently available alternatives, measuring outcomes
      of GI effects, Compliance, product preference,convenience etc.

      To obtain data to support an ACBS submissions for AYMES PRAGUE (to allow for prescription in
      the community at NHS expense).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GI side effects when using AYMES PRAGUE</measure>
    <time_frame>9 DAYS</time_frame>
    <description>Recording of absence/presence of any nausea, vomiting, abdominal pain, bloating / flatulence, when using AYMES PRAGUE as assessed by presence / absence of side effect compared to baseline period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change to bodyweight of subjects when using AYMES PRAGUE</measure>
    <time_frame>9 days</time_frame>
    <description>Recording of bodyweight (in kg) at start of study, start of intervention and end of intervention for comparison to investigate any trend in weight change during the intervention period compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with prescription of AYMES PRAGUE</measure>
    <time_frame>9 days</time_frame>
    <description>Recording of amount of AYMES PRAGUE consumed by subjects compared to amount prescribed. Good compliance = &gt;80% of prescribed being consumed. Same data collected for baseline product and compared with that of AYMES PRAGUE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel habits of subjects when using AYMES PRAGUE - frequency</measure>
    <time_frame>9 days</time_frame>
    <description>Recording of bowel habits whilst subjects consuming AYMES PRAGUE, as assessed by frequency of bowel movements (number of stools per day) and compared to same data recorded during baseline period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel habits of subjects when using AYMES PRAGUE - stool consistency</measure>
    <time_frame>9 days</time_frame>
    <description>Recording of bowel habits whilst subjects consuming AYMES PRAGUE, as assessed by consistency of stools (assessed by Bristol Stool Chart) and compared to same data recorded during baseline period</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients established on an oral nutritional supplement, being prescribed 1-2 oral nutritional supplement (ONS) providing at least 300 kcal/day will be changed onto an equivalent prescription of AYMES PRAGUE for a period of 9 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>AYMES PRAGUE</intervention_name>
    <description>AYMES PRAGUE is a ready to drink, high energy, low volume oral nutritional supplement drink. It provides 300 kcal and 12g protein per 125ml serving. It is a Food for Special Medical Purposes (FSMP) and must therefore be used under medical supervision. It is not designed as a sole source of nutrition.</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (â‰¥18 years) who are able to communicate their views regarding
             acceptability.

          -  Patients established on an oral nutritional supplement, being prescribed 1-2 ONS
             providing approximately 300kcal/day

          -  Patients expected to require oral nutritional supplementation for at least 2 further
             weeks.

          -  Informed consent obtained.

        Exclusion Criteria:

          -  Participation in any other studies involving investigational or marketed products
             concomitantly or within two weeks prior to entry into the study

          -  Patients requiring a milk-free diet

          -  Patients with medical or dietary contraindication to any feed ingredients (see
             appendix 2 of protocol for full list)

          -  Patients with significant renal or hepatic impairment

          -  Patients with swallowing impairment requiring thickened fluids

          -  Patients with inflammatory bowel disease or previous bowel resection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2016</study_first_submitted>
  <study_first_submitted_qc>July 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2016</study_first_posted>
  <last_update_submitted>September 8, 2016</last_update_submitted>
  <last_update_submitted_qc>September 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

